We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Millennium Pharmaceuticals, a division of Takeda Pharmaceutical Co., of Japan, said it will develop
and market a lymphoma drug with Seattle Genetics Inc. The Boston Globe
